Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Pharmacia & Upjohn reveals novel compounds and novel methods of treating NIDDM

Feb. 13, 1998

Sankyo researches new antidiabetic agents

Feb. 13, 1998

Goralatide: a candidate hematopoietic agent from Beaufour Ipsen

Feb. 12, 1998

Adenosine agonists with antilipolytic activity described by Glaxo

Feb. 12, 1998

Macritonin clinical trial update

Feb. 11, 1998

SGLT inhibitors under evaluation at Tanabe as antidiabetic agents

Feb. 11, 1998

Novel compound MK6059 isolated by Meiji Seika/Mitsubishi Chemical

Feb. 11, 1998

Zoledronate compared to other bisphosphonates in rat models of bone loss

Feb. 10, 1998

MMAS results discussed at world congress

Feb. 10, 1998

Pernasal testosterone: a novel administration route for androgenic substitution

Feb. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...